Finance

Lists
Q3 2026 earnings • released • EPS miss -151.67% • Revenue miss -52.36%
See results
MGNX:NASDAQ
MacroGenics Inc
$2.20
-3.93%
(-0.090) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MGNX...
Open
$2.26
High
$2.27
Low
$2.05
Mkt. cap
140.14M
Avg. vol.
911.57K
Volume
0.00
52-wk high
$5.08
52-wk low
$1.32
EPS
-$0.23
Beta
1.33
Shares outstanding
63.91M
No. of employees
293
Open
$2.26
High
$2.27
Low
$2.05
Mkt. cap
140.14M
Avg. vol.
911.57K
Volume
0.00
52-wk high
$5.08
52-wk low
$1.32
EPS
-$0.23
Beta
1.33
Shares outstanding
63.91M
No. of employees
293
News stories
From web sources and news partners
About MacroGenics Inc
CEO-
Employees293
Founded2000
HeadquartersRockville, Maryland, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to MGNX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MGNX in the last 3 months.
Highest
Current $2.20
$11.00 (+400.00%)
Average
$7.00 (+218.18%)
Lowest
$4.00 (+81.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Buy
Maintained
$6.00
+172.7%
11/13/2026
Stephen Willey
Stifel Nicolaus
Hold
Reiterated
$4.00
+81.8%
11/13/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$11.00
+400%
08/17/2026
Tara Bancroft
TD Cowen
Hold
Maintained
-
-
08/13/2026
Robert Burns
H.C. Wainwright
Hold
Reiterated
-
-
05/07/2026
Last report
Nov 12, 2026
Fiscal period
Q3 2026
-$0.32 / -$0.13
-151.67%miss
Revenue / Est. (USD)
18.67M / 39.18M
-52.36%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
41.23M
6.72M
32.83M
18.67M
Cost of goods sold
44.09M
34.97M
38.78M
30.61M
Cost of revenue
44.09M
34.97M
38.78M
30.61M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.24M
9.71M
7.90M
8.36M
Operating expense
9.24M
9.71M
7.90M
8.36M
Total operating expenses
53.32M
44.68M
46.68M
38.97M
Operating income
-12.10M
-37.96M
-13.85M
-20.30M
Other non operating income
-
-
-
-
EBT including unusual items
-14.93M
-41.30M
-69.64M
-21.48M
EBT excluding unusual items
-14.93M
-41.30M
-16.88M
-21.48M
Income tax expense
-777.00K
-
-
-
Effective tax rate
5.20%
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.16M
-36.77M
19.52M
-20.08M
Net profit margin
-34.33%
-547.15%
59.44%
-107.55%
Earnings per share
-0.22
-0.58
1.14
-0.34
Interest and investment income
1.44M
1.55M
1.37M
2.91M
Interest expense
-4.27M
-4.89M
-4.40M
-4.08M
Net interest expenses
-2.84M
-3.34M
-3.03M
-1.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.39M
-36.28M
-13.14M
-20.10M
Gain or loss from assets sale
-10.00K
-
-94.49M
-1.47M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps